137O: Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses
Lena, H, Rizvi, N A, Wolf, J, Cappuzzo, F, Zalcman, G, Baas, P, Mazieres, J, Farsaci, B, Blackwood-Chirchir, M A, Ramalingam, S
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL
Fanale, M., Engert, A., Younes, A., Armand, P., Ansell, S., Zinzani, P.L., Timmerman, J.M., Collins, G.P., Ramchandren, R., Cohen, J.B., De Boer, J.P., Kuruvilla, J., Savage, K.J., Trneny, M., Rodig, S., Shipp, M., Kato, K., Sumbul, A., Farsaci, B., Santoro, A.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age
Milone, G, Mercurio, S, Strano, A, Leotta, S, Pinto, V, Battiato, K, Coppoletta, S, Murgano, P, Farsaci, B, Privitera, A, Giustolisi, R
Published in Cytotherapy (Oxford, England) (2007)
Published in Cytotherapy (Oxford, England) (2007)
Get full text
Journal Article
CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure
Milone, G, Tornello, A, Leotta, S, Poidomani, M, Mercurio, S, Farsaci, B, Consoli, C, Murgano, P, Giustolisi, R
Published in Bone marrow transplantation (Basingstoke) (01.03.2005)
Published in Bone marrow transplantation (Basingstoke) (01.03.2005)
Get full text
Journal Article
Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Hodge, James W., Garnett, Charlie T., Farsaci, Benedetto, Palena, Claudia, Tsang, Kwong‐Yok, Ferrone, Soldano, Gameiro, Sofia R.
Published in International journal of cancer (01.08.2013)
Published in International journal of cancer (01.08.2013)
Get full text
Journal Article
Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Reckamp, K.L., Akerley, W., Calvo, E., Clarke, J., Edelman, M.J., He, K., Moreno, V., Neal, J.W., Owonikoko, T.K., Patel, J.D., Patel, S.P., Riess, J.W., Sacher, A.G., Turcotte, S., Villaruz, L.C., Zauderer, M.G., Farsaci, B., Skoura, N., Chisamore, M., Johnson, M.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1590TiP - Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Reckamp, K.L., Akerley, W., Calvo, E., Clarke, J., Edelman, M.J., He, K., Moreno, V., Neal, J.W., Owonikoko, T.K., Patel, J.D., Patel, S.P., Riess, J.W., Sacher, A.G., Turcotte, S., Villaruz, L.C., Zauderer, M.G., Farsaci, B., Skoura, N., Chisamore, M., Johnson, M.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1590TiPSafety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Reckamp, K L, Akerley, W, Calvo, E, Clarke, J, Edelman, M J, He, K, Moreno, V, Neal, J W, Owonikoko, T K, Patel, J D, Patel, S P, Riess, J W, Sacher, A G, Turcotte, S, Villaruz, L C, Zauderer, M G, Farsaci, B, Skoura, N, Chisamore, M, Johnson, M L
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
137O Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profiling analyses
Lena, H., Rizvi, N.A., Wolf, J., Cappuzzo, F., Zalcman, G., Baas, P., Mazieres, J., Farsaci, B., Blackwood-Chirchir, M.A., Ramalingam, S.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses: 137O
Lena, H, Rizvi, N A, Wolf, J, Cappuzzo, F, Zalcman, G, Baas, P, Mazieres, J, Farsaci, B, Blackwood-Chirchir, M A, Ramalingam, S
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure
Milone, G, Tornello, A, Leotta, S, Poidomani, M, Mercurio, S, Farsaci, B, Consoli, C, Murgano, P, Giustolisi, R
Published in Bone marrow transplantation (01.03.2005)
Get full text
Published in Bone marrow transplantation (01.03.2005)
Report